pCDNA3.1 (-) + SLNCR1 + 12x MS2 bs Citations (1)
Originally described in: The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.Schmidt K, Joyce CE, Buquicchio F, Brown A, Ritz J, Distel RJ, Yoon CH, Novina CD Cell Rep. 2016 May 31;15(9):2025-37. doi: 10.1016/j.celrep.2016.04.018. Epub 2016 May 19. PubMed Journal
Articles Citing pCDNA3.1 (-) + SLNCR1 + 12x MS2 bs
Articles |
---|
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA. Hao Q, Wang P, Dutta P, Chung S, Li Q, Wang K, Li J, Cao W, Deng W, Geng Q, Schrode K, Shaheen M, Wu K, Zhu D, Chen QH, Chen G, Elshimali Y, Vadgama J, Wu Y. Cell Death Dis. 2020 Dec 11;11(12):1052. doi: 10.1038/s41419-020-03235-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.